AD is a chronic inflammatory skin disease affecting both children and adults. AD is
associated with a substantial public health burden secondary to high prevalence in many …

Growing evidence underlines the pivotal role of infant gut colonization in the development of
the immune system. The possibility to modify gut colonization through probiotic …

Background Additional topical treatments for atopic dermatitis (AD) are needed that provide
relief while minimizing risks. Objective We sought to assess the efficacy and safety of …

The implementation of treatment guidelines for atopic dermatitis is challenging, in part
because of different guidance documents being used by different groups of specialists and …

BACKGROUND: Recent data, primarily from Europe, suggest that children with atopic
dermatitis (AD) might be at increased risk of mental health disorders. OBJECTIVE: We aimed …

Using the 2003 National Survey of Children's Health sponsored by the federal Maternal and
Child Health Bureau, we calculated prevalence estimates of eczema nationally and for each …

Transdermal drug delivery systems have been around for decades, and current
technologies (eg, patches, ointments, and creams) enhance the skin permeation of low …

Atopic dermatitis (AD) is driven by a complex gene–environment interaction. Many of the risk
factors and genetic underpinning previously observed for pediatric AD may not apply to …

Atopic dermatitis (AD) is a common, chronic, relapsing, inflammatory skin disease that
affects children and adults. Until recently, the only Food and Drug Administration–approved …

Atopic dermatitis is a common disease of increasing prevalence. Affected individuals must
cope with a significant psychosocial burden, in addition to dealing with the medical aspects …